Lifeline Biotechnologies Inc (LLBO)

[Domains]

This issue was well explained in the latest PR of a month ago (April 25th)
http://www.prweb.com/releases/2017/04/prweb14273437.htm

“The License and Collaboration Agreement between CI and CA brings advantages for both parties,” said Royea. “The opportunity for early market entry and funding from the Asian operations brings additional funding into CI to exercise its option, under an Intellectual Property Asset Option Agreement with the technology’s developer to acquire directly certain patents which previously had been licensed to CI. Those patents are in the process of transferring to CI to be fully owned by CI, and they are licensed to CA under the License and Collaboration Agreement. Furthermore, the License and Collaboration Agreement allows for CI and CA to cooperate on global expansion of the intellectual property portfolio.”

If CISCO had wanted to invest directly in the technology they would have provided the necessary funds for the US launch. However things have not happened that way. Cyrcadia US didn't get the funds from US investors, and had to raise money in Asia at the cost of loosing all the Asian market, now in hand of Cyrcadia Asia, a totally independent company.

The question is not whether patents will be transferred to Cyrcadia US, but when we will hear about it. The answer to this question has several options:
- before June 5th
- on June 5th
- during the month of June
- before Q2
- in the Q2 filling of mid-August
- etc.